The process of discovery and development of a molecule is complex, long and costly. Before making a decision on the offer that best meets your needs, we offer online scientific resources and our latest news to help you get to know us better. Our experts are also at your disposal to help and support you in your research and development program.
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News
Oncolytic Virus Research
Oncodesign Services has been working with ViraTherapeutics GmbH, an Austrian company and subsidiary of Boehringer Ingelheim, on their oncolytic viral immunotherapy since 2018.
How to repurpose your cancer drug to a Molecular RadioTherapy drug candidate
In this blog, Dr Eftychia Koumarianou deals with the ground-breaking and intriguing approach that hides behind the theranostics.
Navigating from molecules to medicines in our chemistry department
Christophe Parsy, Ph.D, MBA, head of the medicinal chemistry team since 2020, presents his team's daily challenges and missions.
Chronic inflammation and cancer: how can preclinical models revolutionize our understanding?
Olivier Duchamp discusses the development of new anti-inflammatory strategies for the prevention and treatment of cancer using a better modeling
Breast cancer awareness month
To progress through new treatments, Oncodesign Services supports since many years pharmaceutical companies with breast cancer models such as PDX and CDX models.
Targeted RNA degradation: Principle and Therapeutic Promises
RNA, or RiboNucleic Acid, is a structured macromolecule which plays a central role in numerous cellular functions.
EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oncodesign Services will be attending to EORTC 2023 ! Fix a meeting now.
Meet Marie!
Every day, as an invivo research technician, Marie participates in the in vivo studies and tests the effects of a new molecule or a new product. Discover her journey and learn more about working in a lab as a technician.
Breaking Barriers in Oncology Drug Development: Unveiling the Potential of 3D Cell Models for Drug Discovery
Blog: 3D Cell models are revolutionizing Cancer Drug Development. Here, we present the main advantages to better understand tumor complexity
Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B
Dual-specificity, tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) recently attracted attention due to their central involvement in various pathologies.
CADD: computer tools and chemists combine to make better drug leads
Sylvain Lozano, computational chemist, explains the important role these tools play in our drug discovery journey.